نتائج البحث - Jamie Geier

  • يعرض 1 - 9 نتائج من 9
تنقيح النتائج
  1. 1
    Chromosomal position of a V(H) gene segment determines its activation and inactivation as a substrate for V(D)J recombination

    Chromosomal position of a V(H) gene segment determines its activation and inactivation as a substrate for V(D)J recombination حسب Bates, Jamie Geier, Cado, Dragana, Nolla, Hector, Schlissel, Mark S.

    منشور في 2007
    احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل
    نص
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Effects of tofacitinib and other DMARDs on lipid profiles in rheumatoid arthritis: implications for the rheumatologist

    Effects of tofacitinib and other DMARDs on lipid profiles in rheumatoid arthritis: implications for the rheumatologist حسب Christina Charles‐Schoeman, Miguel Á. González‐Gay, Irina V Kaplan, M. Boy, Jamie Geier, Zhen Luo, Andrea Zuckerman, Richard J. Riese

    منشور في 2016
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Completed and Attempted Suicides Among 18,154 Subjects With Schizophrenia Included in a Large Simple Trial

    Completed and Attempted Suicides Among 18,154 Subjects With Schizophrenia Included in a Large Simple Trial حسب W. Wolfgang Fleischhacker, John M. Kane, Jamie Geier, Onur N. Karayal, Sheela Kolluri, Sybil M. Eng, Robert F. Reynolds, Brian L. Strom

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Tofacitinib, an oral Janus kinase inhibitor: analysis of malignancies across the rheumatoid arthritis clinical development programme

    Tofacitinib, an oral Janus kinase inhibitor: analysis of malignancies across the rheumatoid arthritis clinical development programme حسب Jeffrey R. Curtis, Eun Bong Lee, Irina V Kaplan, Kenneth Kwok, Jamie Geier, Birgitta Benda, Koshika Soma, Lisy Wang, Richard J. Riese

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Cardiovascular safety findings in patients with rheumatoid arthritis treated with tofacitinib, an oral Janus kinase inhibitor

    Cardiovascular safety findings in patients with rheumatoid arthritis treated with tofacitinib, an oral Janus kinase inhibitor حسب Christina Charles‐Schoeman, Pierre Wicker, Miguel Á. González‐Gay, M. Boy, Andrea Zuckerman, Koshika Soma, Jamie Geier, Kenneth Kwok, Richard J. Riese

    منشور في 2016
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Systematic review and meta-analysis of serious infections with tofacitinib and biologic disease-modifying antirheumatic drug treatment in rheumatoid arthritis clinical trials

    Systematic review and meta-analysis of serious infections with tofacitinib and biologic disease-modifying antirheumatic drug treatment in rheumatoid arthritis clinical trials حسب Vibeke Strand, Sima Ahadieh, Jonathan French, Jamie Geier, Sriram Krishnaswami, Sujatha Menon, Tina Checchio, Thomas G. Tensfeldt, Elaine Hoffman, Richard J. Riese, M. Boy, Juan J. Gómez‐Reino

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis

    Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis حسب Megan E. B. Clowse, Steven R. Feldman, John D. Isaacs, Alexa B. Kimball, Vibeke Strand, Richard B. Warren, Daniel Xibillé, Yan Chen, Donald E. Frazier, Jamie Geier, James Proulx, Amy Marren

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials

    Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials حسب Stanley Cohen, Yoshiya Tanaka, Xavier Mariette, Jeffrey R. Curtis, Eun Bong Lee, Peter Nash, Kevin Winthrop, Christina Charles‐Schoeman, Krishan Thirunavukkarasu, Ryan DeMasi, Jamie Geier, Kenneth Kwok, Lisy Wang, Richard J. Riese, J. Wollenhaupt

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Postapproval Comparative Safety Study of Tofacitinib and Biological Disease‐Modifying Antirheumatic Drugs: 5‐Year Results from a United States–Based Rheumatoid Arthritis Registry

    Postapproval Comparative Safety Study of Tofacitinib and Biological Disease‐Modifying Antirheumatic Drugs: 5‐Year Results from a United States–Based Rheumatoid Arthritis Registry... حسب Joel M. Kremer, Clifton O. Bingham, Laura C. Cappelli, Jeffrey D. Greenberg, Ann Madsen, Jamie Geier, Jose L. Rivas, Alina M. Onofrei, Christine Barr, Dimitrios A. Pappas, Heather J. Litman, Kimberly J. Dandreo, Andrea Shapiro, Carol A. Connell, Arthur Kavanaugh

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: